Timedora
Free Online Flashcard Deck

7 Antithrombotic Therapy and Bleeding Risk Free Online Flashcards

Study 7 Antithrombotic Therapy and Bleeding Risk with 12 free online flashcards. Review key terms, definitions, and concepts with this interactive flashcard deck.

12 cards
01
Front

How do anticoagulants differ from antiplatelet medicines?

Back

Anticoagulants interfere with clotting factors and are used especially for venous clots and emboli; antiplatelet medicines inhibit platelet activation or aggregation and are used especially to prevent arterial events.

02
Front

What happens to bleeding risk when antithrombotic agents are combined?

Back

Combining antithrombotic medicines generally increases bleeding risk.

03
Front

What routine monitoring is used for therapeutic IV UFH?

Back

For therapeutic IV UFH, monitor aPTT or heparin anti-Xa according to protocol; also monitor platelet count and hemoglobin/hematocrit.

04
Front

What findings raise concern for heparin-induced thrombocytopenia?

Back

A falling platelet count during heparin exposure, especially with new thrombosis, raises concern for HIT. Promptly notify the prescriber and follow the suspected-HIT protocol.

05
Front

Which bleeding situations require emergency escalation?

Back

Bleeding into a critical site, such as the brain, spinal canal, or retroperitoneum, or bleeding with hemodynamic instability requires emergency escalation.

06
Front

Does a normal PT/INR or aPTT rule out clinically important DOAC activity?

Back

No. A normal PT/INR or aPTT does not exclude clinically important DOAC activity; a drug-specific assay may be appropriate when testing is needed.

07
Front

What reversal approach is commonly used for severe warfarin-related bleeding?

Back

For severe warfarin-related bleeding, a commonly used approach is four-factor prothrombin complex concentrate plus IV vitamin K; follow local protocol.

08
Front

What should patients do about missed doses or stopping antithrombotic therapy?

Back

Take the medicine exactly as prescribed; do not double a missed dose or stop treatment without consulting a clinician.

09
Front

How is warfarin monitored, and what can change its effect?

Back

Warfarin is monitored with PT/INR. Its effect can change with illness, diet, dose changes, and interacting medicines.

10
Front

What is an important limitation of INR monitoring for DOACs?

Back

Routine INR does not reliably measure DOAC anticoagulant effect. Periodically assess CBC and renal function, and reassess as clinically indicated.

11
Front

Do INR or aPTT measure the effect of antiplatelet medicines?

Back

Routine INR or aPTT does not measure platelet inhibition. Assess for clinical bleeding and obtain a CBC when indicated.

12
Front

Why is HIT dangerous despite a low platelet count?

Back

HIT is prothrombotic despite thrombocytopenia. The suspected-HIT protocol generally includes stopping heparin and starting a non-heparin anticoagulant when indicated.